Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Tornheim JA"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-10 z 10
    Tytuł:
    Swimming against the STREAM: Why STREAM 2 data cannot be easily applied to MDR-TB patients across India.
    Autorzy:
    Udwadia ZF; Department of Respiratory Medicine, P. D. Hinduja National Hospital and Medical Research Centre, Mumbai, Maharashtra, India.
    Patel JM; Department of Respiratory Medicine, P. D. Hinduja National Hospital and Medical Research Centre, Mumbai, Maharashtra, India.
    Batyala M; Department of Respiratory Medicine, P. D. Hinduja National Hospital and Medical Research Centre, Mumbai, Maharashtra, India.
    Tornheim JA; Center for Infectious Diseases in India, Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, USA.
    Rodrigues C; Department of Microbiology, P. D. Hinduja National Hospital and Medical Research Centre, Mumbai, Maharashtra, India.
    Pokaż więcej
    Źródło:
    Lung India : official organ of Indian Chest Society [Lung India] 2023 May-Jun; Vol. 40 (3), pp. 290-291.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Increased Moxifloxacin Dosing Among Patients With Multidrug-Resistant Tuberculosis With Low-Level Resistance to Moxifloxacin Did Not Improve Treatment Outcomes in a Tertiary Care Center in Mumbai, India.
    Autorzy:
    Tornheim JA; Center for Clinical Global Health Education, Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Udwadia ZF; Department of Respiratory Medicine, P. D. Hinduja National Hospital and Medical Research Centre, Mumbai, Maharashtra, India.
    Arora PR; Department of Laboratory Medicine, P. D. Hinduja National Hospital and Medical Research Centre, Mumbai, Maharashtra, India.
    Gajjar I; Department of Laboratory Medicine, P. D. Hinduja National Hospital and Medical Research Centre, Mumbai, Maharashtra, India.
    Sharma S; Department of Laboratory Medicine, P. D. Hinduja National Hospital and Medical Research Centre, Mumbai, Maharashtra, India.
    Karane M; Department of Laboratory Medicine, P. D. Hinduja National Hospital and Medical Research Centre, Mumbai, Maharashtra, India.
    Sawant N; Department of Laboratory Medicine, P. D. Hinduja National Hospital and Medical Research Centre, Mumbai, Maharashtra, India.
    Kharat N; Department of Laboratory Medicine, P. D. Hinduja National Hospital and Medical Research Centre, Mumbai, Maharashtra, India.
    Blum AJ; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Shivakumar SVBY; Johns Hopkins University-India Office (Center for Clinical Global Health Education), Pune, Maharashtra, India.
    Gupte AN; Center for Clinical Global Health Education, Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Gupte N; Center for Clinical Global Health Education, Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Johns Hopkins University-India Office (Center for Clinical Global Health Education), Pune, Maharashtra, India.
    Mullerpattan JB; Department of Respiratory Medicine, P. D. Hinduja National Hospital and Medical Research Centre, Mumbai, Maharashtra, India.
    Pinto LM; Department of Respiratory Medicine, P. D. Hinduja National Hospital and Medical Research Centre, Mumbai, Maharashtra, India.
    Ashavaid TF; Department of Laboratory Medicine, P. D. Hinduja National Hospital and Medical Research Centre, Mumbai, Maharashtra, India.
    Gupta A; Center for Clinical Global Health Education, Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
    Rodrigues C; Department of Microbiology, P. D. Hinduja National Hospital and Medical Research Centre, Mumbai, Maharashtra, India.
    Pokaż więcej
    Źródło:
    Open forum infectious diseases [Open Forum Infect Dis] 2021 Dec 23; Vol. 9 (2), pp. ofab615. Date of Electronic Publication: 2021 Dec 23 (Print Publication: 2022).
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Linezolid resistance in Mycobacterium tuberculosis isolates at a tertiary care centre in Mumbai, India.
    Autorzy:
    Nambiar R; Department of Microbiology, PD Hinduja Hospital & MRC, Mumbai, Maharashtra, India.
    Tornheim JA; Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
    Diricks M; Department of Data Analytics, Applied Maths NV, BioMérieux, 9830 Sint-Martens-Latem, Belgium.
    De Bruyne K; Department of Data Analytics, Applied Maths NV, BioMérieux, 9830 Sint-Martens-Latem, Belgium.
    Sadani M; Department of Microbiology, PD Hinduja Hospital & MRC, Mumbai, Maharashtra, India.
    Shetty A; Department of Microbiology, PD Hinduja Hospital & MRC, Mumbai, Maharashtra, India.
    Rodrigues C; Department of Microbiology, PD Hinduja Hospital & MRC, Mumbai, Maharashtra, India.
    Pokaż więcej
    Źródło:
    The Indian journal of medical research [Indian J Med Res] 2021 Jul; Vol. 154 (1), pp. 85-89.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Mycobacterium tuberculosis*/genetics
    Tuberculosis, Multidrug-Resistant*/drug therapy
    Tuberculosis, Multidrug-Resistant*/epidemiology
    Tuberculosis, Multidrug-Resistant*/genetics
    Antitubercular Agents/pharmacology ; Antitubercular Agents/therapeutic use ; Drug Resistance, Multiple, Bacterial ; Humans ; Linezolid/pharmacology ; Linezolid/therapeutic use ; Microbial Sensitivity Tests ; Mutation ; Tertiary Care Centers
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Delayed Rise of Oral Fluid Antibodies, Elevated BMI, and Absence of Early Fever Correlate With Longer Time to SARS-CoV-2 RNA Clearance in a Longitudinally Sampled Cohort of COVID-19 Outpatients.
    Autorzy:
    Antar AAR; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Yu T; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Pisanic N; Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
    Azamfirei R; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Tornheim JA; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Brown DM; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Kruczynski K; Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
    Hardick JP; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Sewell T; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Jang M; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Church T; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Walch SN; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Reuland C; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Bachu VS; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Littlefield K; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
    Park HS; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
    Ursin RL; Department of Biochemistry and Molecular Biology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
    Ganesan A; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
    Kusemiju O; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Barnaba B; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Charles C; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Prizzi M; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Johnstone JR; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Payton C; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Dai W; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Fuchs J; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Massaccesi G; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Armstrong DT; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Townsend JL; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Keller SC; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Demko ZO; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Hu C; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Wang MC; Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
    Sauer LM; Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Mostafa HH; Department of Biochemistry and Molecular Biology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
    Keruly JC; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Mehta SH; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
    Klein SL; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Department of Biochemistry and Molecular Biology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
    Cox AL; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Pekosz A; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
    Heaney CD; Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
    Thomas DL; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Blair PW; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Manabe YC; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
    Pokaż więcej
    Źródło:
    Open forum infectious diseases [Open Forum Infect Dis] 2021 Apr 16; Vol. 8 (6), pp. ofab195. Date of Electronic Publication: 2021 Apr 16 (Print Publication: 2021).
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    The Clinical Course of COVID-19 in the Outpatient Setting: A Prospective Cohort Study.
    Autorzy:
    Blair PW; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Austere Environments Consortium for Enhanced Sepsis Outcomes, Henry M. Jackson Foundation, Bethesda, Maryland, USA.
    Brown DM; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Jang M; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Antar AAR; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Keruly JC; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Bachu VS; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Townsend JL; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Tornheim JA; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Keller SC; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Sauer L; Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Thomas DL; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Manabe YC; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
    Pokaż więcej
    Corporate Authors:
    Ambulatory COVID Study Team
    Źródło:
    Open forum infectious diseases [Open Forum Infect Dis] 2021 Jan 05; Vol. 8 (2), pp. ofab007. Date of Electronic Publication: 2021 Jan 05 (Print Publication: 2021).
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Aspergillosis Complicating Severe Coronavirus Disease.
    Autorzy:
    Marr KA
    Platt A
    Tornheim JA
    Zhang SX
    Datta K
    Cardozo C
    Garcia-Vidal C
    Pokaż więcej
    Źródło:
    Emerging infectious diseases [Emerg Infect Dis] 2021 Jan; Vol. 27 (1). Date of Electronic Publication: 2020 Oct 21.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't; Review
    MeSH Terms:
    SARS-CoV-2*
    COVID-19/*complications
    Pulmonary Aspergillosis/*complications
    Humans ; Risk Factors
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Integration of metabolomics and transcriptomics reveals novel biomarkers in the blood for tuberculosis diagnosis in children.
    Autorzy:
    Dutta NK; Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University School of Medicine, 1551 East Jefferson Street, Room 110, Baltimore, MD, 21287, USA. .
    Tornheim JA; Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University School of Medicine, 1551 East Jefferson Street, Room 110, Baltimore, MD, 21287, USA.; Center for Clinical Global Health Education, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
    Fukutani KF; Laboratório de Inflamação E Biomarcadores, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Brazil.; Curso de Medicina, Faculdade de Tecnologia E Ciências, Salvador, Brazil.
    Paradkar M; Byramjee Jeejeebhoy Government Medical College, Johns Hopkins University Clinical Research Site, Pune, Maharashtra, India.
    Tiburcio RT; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Brazil.; Curso de Medicina, Faculdade de Tecnologia E Ciências, Salvador, Brazil.
    Kinikar A; Byramjee Jeejeebhoy Government Medical College, Pune, Maharashtra, India.
    Valvi C; Byramjee Jeejeebhoy Government Medical College, Pune, Maharashtra, India.
    Kulkarni V; Byramjee Jeejeebhoy Government Medical College, Johns Hopkins University Clinical Research Site, Pune, Maharashtra, India.
    Pradhan N; Byramjee Jeejeebhoy Government Medical College, Johns Hopkins University Clinical Research Site, Pune, Maharashtra, India.
    Shivakumar SVBY; Johns Hopkins University - India Office (CCGHE), Pune, Maharashtra, India.
    Kagal A; Byramjee Jeejeebhoy Government Medical College, Pune, Maharashtra, India.
    Gupte A; Center for Clinical Global Health Education, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
    Gupte N; Center for Clinical Global Health Education, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Byramjee Jeejeebhoy Government Medical College, Johns Hopkins University Clinical Research Site, Pune, Maharashtra, India.
    Mave V; Center for Clinical Global Health Education, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Byramjee Jeejeebhoy Government Medical College, Johns Hopkins University Clinical Research Site, Pune, Maharashtra, India.
    Gupta A; Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University School of Medicine, 1551 East Jefferson Street, Room 110, Baltimore, MD, 21287, USA.; Center for Clinical Global Health Education, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Byramjee Jeejeebhoy Government Medical College, Johns Hopkins University Clinical Research Site, Pune, Maharashtra, India.; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
    Andrade BB; Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Brazil.; Curso de Medicina, Faculdade de Tecnologia E Ciências, Salvador, Brazil.; Byramjee Jeejeebhoy Government Medical College, Johns Hopkins University Clinical Research Site, Pune, Maharashtra, India.; Universidade Salvador (UNIFACS), Laureate Universities, Salvador, Brazil.; Escola Bahiana de Medicina E Saúde Pública (EBMSP), Salvador, Brazil.
    Karakousis PC; Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University School of Medicine, 1551 East Jefferson Street, Room 110, Baltimore, MD, 21287, USA. .; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. .
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2020 Nov 11; Vol. 10 (1), pp. 19527. Date of Electronic Publication: 2020 Nov 11.
    Typ publikacji:
    Journal Article; Observational Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Biomarkers/*blood
    Tuberculosis/*blood
    Tuberculosis/*diagnosis
    Tuberculosis/*drug therapy
    Adolescent ; Antitubercular Agents/therapeutic use ; Case-Control Studies ; Child ; Chromatography, Liquid ; Family Characteristics ; Female ; Gene Expression Profiling ; Humans ; Longitudinal Studies ; Male ; Mass Spectrometry/methods ; Metabolomics/methods ; Treatment Outcome
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Few eligible for the newly recommended short course MDR-TB regimen at a large Mumbai private clinic.
    Autorzy:
    Udwadia ZF; Medical Research Centre, P.D. Hinduja National Hospital, Veer Savarkar Road, Mahim, Mumbai, Maharashtra, 400016, India. .
    Tornheim JA; Division of Infectious Diseases, Center for Clinical Global Health Education, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Phipps 521, Baltimore, MD, 21287, USA. tornheim@jhu.edu.
    Ganatra S; Medical Research Centre, P.D. Hinduja National Hospital, Veer Savarkar Road, Mahim, Mumbai, Maharashtra, 400016, India.
    DeLuca A; Division of Global Disease Epidemiology and Control, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, 21287, USA.
    Rodrigues CS; Medical Research Centre, P.D. Hinduja National Hospital, Veer Savarkar Road, Mahim, Mumbai, Maharashtra, 400016, India.
    Gupta A; Division of Infectious Diseases, Center for Clinical Global Health Education, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Phipps 521, Baltimore, MD, 21287, USA.
    Pokaż więcej
    Źródło:
    BMC infectious diseases [BMC Infect Dis] 2019 Jan 28; Vol. 19 (1), pp. 94. Date of Electronic Publication: 2019 Jan 28.
    Typ publikacji:
    Journal Article; Observational Study
    MeSH Terms:
    Eligibility Determination*/standards
    Eligibility Determination*/statistics & numerical data
    Patient Selection*
    Antitubercular Agents/*administration & dosage
    Tuberculosis, Multidrug-Resistant/*drug therapy
    Tuberculosis, Multidrug-Resistant/*epidemiology
    Adult ; Ambulatory Care Facilities ; Cohort Studies ; Drug Administration Schedule ; Female ; Fluoroquinolones/administration & dosage ; Guideline Adherence/statistics & numerical data ; Hospitals, Private ; Humans ; India/epidemiology ; Male ; Middle Aged ; Rifampin/administration & dosage ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Improved completion rates and characterization of drug reactions with an intensive Chagas disease treatment program in rural Bolivia.
    Autorzy:
    Tornheim JA; Combined Internal Medicine/Pediatrics Residency Program, Yale School of Medicine, New Haven, Connecticut, United States of America.
    Lozano Beltran DF
    Gilman RH
    Castellon M
    Solano Mercado MA
    Sullca W
    Torrico F
    Bern C
    Pokaż więcej
    Źródło:
    PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2013 Sep 19; Vol. 7 (9), pp. e2407. Date of Electronic Publication: 2013 Sep 19 (Print Publication: 2013).
    Typ publikacji:
    Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Antiprotozoal Agents/*adverse effects
    Antiprotozoal Agents/*therapeutic use
    Chagas Disease/*drug therapy
    Nitroimidazoles/*adverse effects
    Nitroimidazoles/*therapeutic use
    Adolescent ; Adult ; Bolivia ; Cohort Studies ; Drug-Related Side Effects and Adverse Reactions/epidemiology ; Drug-Related Side Effects and Adverse Reactions/pathology ; Female ; Humans ; Male ; Medication Adherence ; Middle Aged ; Prospective Studies ; Rural Population ; Treatment Outcome ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Chagas cardiomyopathy in the context of the chronic disease transition.
    Autorzy:
    Hidron AI; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America.
    Gilman RH
    Justiniano J
    Blackstock AJ
    Lafuente C
    Selum W
    Calderon M
    Verastegui M
    Ferrufino L
    Valencia E
    Tornheim JA
    O'Neal S
    Comer R
    Galdos-Cardenas G
    Bern C
    Pokaż więcej
    Corporate Authors:
    Chagas Disease Working Group in Peru and Bolivia
    Źródło:
    PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2010 May 18; Vol. 4 (5), pp. e688. Date of Electronic Publication: 2010 May 18.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural
    MeSH Terms:
    Chagas Cardiomyopathy/*epidemiology
    Chagas Cardiomyopathy/*pathology
    Trypanosoma cruzi/*isolation & purification
    Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antibodies, Protozoan/blood ; Bolivia/epidemiology ; Chagas Cardiomyopathy/complications ; Chagas Cardiomyopathy/mortality ; Chronic Disease ; DNA, Protozoan/blood ; Enzyme-Linked Immunosorbent Assay ; Female ; Heart Failure/epidemiology ; Heart Failure/etiology ; Humans ; Male ; Middle Aged ; Polymerase Chain Reaction ; Prevalence ; Risk Factors ; Trypanosoma cruzi/genetics ; Trypanosoma cruzi/immunology ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
      Wyświetlanie 1-10 z 10

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies